Definitive Healthcare (DH) Research & Development (2020 - 2026)

Definitive Healthcare (DH) has 7 years of Research & Development data on file, last reported at $6.5 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development fell 30.13% year-over-year to $6.5 million; the trailing twelve-month figure through Mar 2026 stood at $32.0 million (down 10.4% YoY), and the FY2025 full-year result was $34.8 million, down 4.77% from the prior year.
• Research & Development for Q1 2026 stood at $6.5 million, down from $10.0 million in the prior quarter.
• Across five years, Research & Development topped out at $11.6 million in Q4 2023 and bottomed at $6.5 million in Q1 2026.
• The 5-year median for Research & Development is $9.3 million (2025), against an average of $9.1 million.
• The widest annual swing landed in 2022, when Research & Development jumped 103.55%; it then sank 32.32% in 2024.
• A 5-year view of Research & Development shows it stood at $10.1 million in 2022, then climbed by 14.22% to $11.6 million in 2023, then dropped by 22.36% to $9.0 million in 2024, then grew by 10.82% to $10.0 million in 2025, then slumped by 34.71% to $6.5 million in 2026.
• The last three Research & Development figures came in at $6.5 million (Q1 2026), $10.0 million (Q4 2025), and $7.6 million (Q3 2025), per Business Quant data.

Peer Comparison